Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
The European Respiratory Journal|November 17, 1998
Simultaneous laboratory-based comparison of ResMed Autoset with polysomnography in the diagnosis of sleep apnoea/hypopnoea syndromeP Mayer, J C Meurice, F Philip-Joet, et al.
British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.
Revue Des Maladies Respiratoires|January 14, 2012
[Home telemonitoring of CPAP: a feasibility study]J L Fraysse, N Delavillemarque, B Gasparutto, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1993
A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infectionsP Léophonte, A Bertrand, G Nouvet, et al.
Respiratory Medicine|November 1, 1989
A prospective randomized comparison of fine needle aspiration biopsy and fibreoptic bronchoscopy in the investigation of peripheral pulmonary opacitiesC R Swinburn, D Veale, E T Peel, et al.
Presse Medicale (Paris, France : 1983)|January 28, 1995
[Chemotherapy of small cell bronchial cancers. Prognostic importance of complete response (1,280 patients). Groupe Petites Cellules]B Lebeau, C Chastang, M P Schuller, et al.
The European Respiratory Journal|March 8, 2000
Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Association Nationale pour le Traitement A Domicile de l'Insuffisance Respiratoire chroniqueD Veale, E Chailleux, A Hoorelbeke-Ramon, et al.
Annals of the Rheumatic Diseases|January 30, 2009
Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritisJ Martin, C Walsh, A Gibbs, et al.
The European Respiratory Journal|February 26, 2011
Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot studyA Abdellaoui, C Préfaut, F Gouzi, et al.
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.
Pageof 24